SCHEMBL20394149

SCHEMBL20394149

COc1ccccc1-c1ccnnc1Oc1ccc(C(F)(F)F)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.40
GPBAR1 Q8TDU6 2/20 0.37
KMT2A Q03164 3/20 0.36
PPP1CA P62136 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA3 P34903 1/20 0.36
HPGD P15428 4/20 0.36
KDM4E B2RXH2 3/20 0.36
NPSR1 Q6W5P4 3/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 2/20 0.36
MITF O75030 1/20 0.36
STAT3 P40763 1/20 0.36
SLC22A12 Q96S37 1/20 0.35
PTGS2 P35354 2/20 0.35
ALDH1A1 P00352 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18661517 0.87 PDE10A (0.46) PDE10AKMT2APPP1CALMNAALDH1A1
SCHEMBL20394199 0.82 KDM4E (0.42) PDE10AKMT2APPP1CAGABRA1GABRG2
SCHEMBL20394296 0.81 KMT2A (0.40) PDE10AKMT2APPP1CAGABRA1GABRG2
SCHEMBL18661341 0.81 CYP3A4 (0.47) KMT2AHPGDKDM4ELMNASLC22A12
SCHEMBL20394444 0.80 KDM4E (0.38) PDE10AGPBAR1KMT2APPP1CAGABRA1
SCHEMBL20394501 0.80 PDE10A (0.51) PDE10AGPBAR1
SCHEMBL18661516 0.79 PDE10A (0.45) PDE10AKMT2APPP1CALMNAALDH1A1
SCHEMBL20394376 0.79 DRD1 (0.38) PDE10AKMT2APPP1CAGABRA1GABRG2
SCHEMBL20394173 0.78 SYK (0.40) PDE10AGPBAR1KMT2APPP1CAL3MBTL1
SCHEMBL18661511 0.78 GPBAR1 (0.41) PDE10AGPBAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351533-B1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMA CO LTD (JP) 2025-07-23 EP disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647675-B2 Biaryl derivative and medicine containing same MAN2B1, CBR3, MANBA PDE10A 4605/4885GPBAR1 2116/4885KMT2A 544/4885
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME MAN2B1, CBR3, MANBA PDE10A 4605/4885GPBAR1 2116/4885KMT2A 544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.